SRES-696-119
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2076-2077; text: CR S2085-2086)
Sponsored by Rick Scott (R-FL)
What it does
This resolution expresses the Senate's support for designating April 2026 as "Parkinson's Awareness Month." It is a commemorative measure only — it does not create any new programs, allocate funding, change existing law, or impose any requirements on any person, agency, or state. It was passed by unanimous consent.
Who benefits
People living with Parkinson's disease (approximately 1 million Americans), their caregivers and families, and Parkinson's advocacy and research organizations, who may gain increased public visibility and awareness. Healthcare providers who treat Parkinson's patients may also benefit from heightened public attention to the disease.
Who is hurt
No group is materially harmed by this resolution. It carries no legal force, imposes no costs, and creates no mandates.
Supporters argue
Supporters argue that awareness designations serve a meaningful public health function by drawing national attention to diseases that affect millions of Americans and their families. They contend that increased awareness can encourage early diagnosis, promote research funding advocacy, and reduce the social stigma sometimes associated with neurological conditions like Parkinson's disease.
Opponents argue
Opponents might argue that commemorative resolutions consume limited legislative time and floor resources without producing any binding policy change, funding, or measurable health outcome. They contend that if Congress wishes to address Parkinson's disease meaningfully, it should instead direct resources toward research funding or patient support programs with enforceable, concrete effects.